varolanib | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

33 results for “varolanib”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Pharmacokinetic Study of Vorolanib Tablets in Trial Participants With Hepatic Impairment

36 participants · First posted Sep 9, 2026

Active, not recruiting

Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma

60 participants · First posted Jul 2, 2025

Not yet recruiting

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

37 participants · First posted Aug 29, 2024

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

88 participants · First posted Jul 11, 2018

Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

11 participants · First posted May 4, 2020

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

1,168 participants · First posted Mar 14, 2003

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

25 participants · First posted Jul 6, 2006

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

855 participants · First posted Mar 14, 2003

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

155 participants · First posted Nov 6, 2003

Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery

34 participants · First posted Nov 26, 2007

Page 1 of 3